Ramiah Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Sell
4,709
-485
-9% -$40.6K 0.33% 49
2026
Q1
$416K Sell
5,194
-636
-11% -$52.4K 2.78% 18
2025
Q4
$497K Sell
5,830
-179
-3% -$14.7K 0.43% 40
2025
Q3
$467K Buy
6,009
+20
+0.3% +$1.56K 0.41% 43
2025
Q2
$468K Sell
5,989
-524
-8% -$39.1K 0.5% 41
2025
Q1
$472K Sell
6,513
-401
-6% -$28.7K 0.45% 33
2024
Q4
$512K Buy
6,914
+1,286
+23% +$90K 0.47% 38
2024
Q3
$371K Sell
5,628
-2,189
-28% -$159K 0.35% 54
2024
Q2
$722K Sell
7,817
-2,036
-21% -$180K 0.71% 39
2024
Q1
$942K Buy
9,853
+347
+4% +$29.1K 0.89% 22
2023
Q4
$725K Buy
9,506
+1,200
+14% +$83.5K 0.68% 33
2023
Q3
$575K Sell
8,306
-1,961
-19% -$158K 0.6% 40
2023
Q2
$968K Buy
+10,267
New +$892K 0.95% 26
2021
Q4
Sell
-8,716
Closed -$987K 78
2021
Q3
$987K Sell
8,716
-78
-0.9% -$8.9K 0.71% 28
2021
Q2
$911K Sell
8,794
-7
-0.1% -$660 0.65% 30
2021
Q1
$736K Buy
8,801
+994
+13% +$84K 0.55% 43
2020
Q4
$712K Buy
7,807
+354
+5% +$29.4K 0.59% 33
2020
Q3
$595K Sell
7,453
-55
-0.7% -$4.29K 0.58% 36
2020
Q2
$519K Buy
+7,508
New +$534K 0.55% 42

Other funds holding EW

Ramiah Investment Group's EW Position: Q2 2026 in Review

Ramiah Investment Group reduced its Edwards Lifesciences (EW) stake by 9.3% in Q2 2026, selling an estimated $40.6K and leaving 4,709 shares worth $426K. The position accounts for 0.33% of the portfolio, ranked #49.

Ramiah Investment Group first reported a position in EW in Q2 2020 and has held it in 19 quarters since. The position peaked at $987K in Q3 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ramiah Investment Group held 4,709 shares of Edwards Lifesciences worth $426K as of Q2 2026.
  • Ramiah Investment Group sold 485 Edwards Lifesciences shares in Q2 2026, an estimated $40.6K.
  • Edwards Lifesciences made up 0.33% of Ramiah Investment Group's portfolio in Q2 2026, its #49 holding.
  • Ramiah Investment Group first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 19 quarters since.
  • Ramiah Investment Group's Edwards Lifesciences position peaked at $987K in Q3 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.